Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
Koga M, Toyoda K, Yamagami H, Okuda S, Okada Y, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Hasegawa Y, Kario K, Osaki M, Miyagi T, Endo K, Nagatsuka K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. Koga M, et al. J Hypertens. 2012 Dec;30(12):2357-64. doi: 10.1097/HJH.0b013e328359311b. J Hypertens. 2012. PMID: 22990355 Clinical Trial.
OBJECTIVE: Optimal blood pressure (BP) control in acute intracerebral hemorrhage (ICH) remains controversial. We determined the effects of SBP lowering to 160 mmHg or more using intravenous nicardipine for acute ICH patients. ...CONCLUSION: SBP lowering to 160 mmHg …
OBJECTIVE: Optimal blood pressure (BP) control in acute intracerebral hemorrhage (ICH) remains controversial. We determined the effec …
A multicenter, prospective, observational study of warfarin-associated intracerebral hemorrhage: The SAMURAI-WAICH study.
Osaki M, Koga M, Maeda K, Hasegawa Y, Nakagawara J, Furui E, Todo K, Kimura K, Shiokawa Y, Okada Y, Okuda S, Kario K, Yamagami H, Minematsu K, Kitazono T, Toyoda K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. Osaki M, et al. J Neurol Sci. 2015 Dec 15;359(1-2):72-7. doi: 10.1016/j.jns.2015.10.031. Epub 2015 Oct 23. J Neurol Sci. 2015. PMID: 26671089 Clinical Trial.
On the other hand, thromboembolism may occur with reversal or withholding of anticoagulant therapy. The current status of acute hemostatic treatments and clinical outcomes in WAICH patients was investigated. METHODS: WAICH patients admitted within 3 days of onset were pros …
On the other hand, thromboembolism may occur with reversal or withholding of anticoagulant therapy. The current status of acute hemos …
Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register.
Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-factor Assessment and Improvement Study Investigators. Toyoda K, et al. Stroke. 2009 Nov;40(11):3591-5. doi: 10.1161/STROKEAHA.109.562991. Epub 2009 Sep 17. Stroke. 2009. PMID: 19762694
BACKGROUND AND PURPOSE: A retrospective, multicenter, observational study was conducted to document clinical outcomes and to identify outcome predictors in patients treated with low-dose intravenous recombinant tissue plasminogen activator (0.6 mg/kg alteplase), which was approve …
BACKGROUND AND PURPOSE: A retrospective, multicenter, observational study was conducted to document clinical outcomes and to identify outcom …